MGMT underexpression	Glioblastoma	MGMT underexpression	Glioblastoma	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3
MGMT underexpression	Pituitary Gland Carcinoma	MGMT underexpression	Pituitary Gland Carcinoma	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3
MGMT underexpression	Neuroendocrine Tumor	MGMT underexpression	Neuroendocrine Tumor	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3	temozolomide Sensitive: C3 – Early Trials temozolomide Sensitive : C3
MGMT underexpression	Colorectal Cancer	MGMT underexpression	Colorectal Cancer	olaparib + temozolomide Sensitive: C3 – Early Trials olaparib + temozolomide Sensitive : C3	olaparib + temozolomide Sensitive: C3 – Early Trials olaparib + temozolomide Sensitive : C3

MGMT underexpression

Associations